MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
39.32%
Quick Ratio
19.41%
Cash Ratio
10.30%
Debt to Asset Ratio
35.43%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Less accumulated depreciation
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Common stock and additional paid...
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
331
207
900
1,105
Accounts receivable, net
56
37
12
41
Inventory
640
638
640
658
Current investment
23
28
38
25
Asset held for sale
-
-
0
0
Deposits and advances
214
237
200
175
Total current assets
1,264
1,147
1,790
2,004
Intangible assets, net
5,507
5,268
5,101
4,879
Property, plant and equipment, gross
3,828
3,816
3,811
3,886
Less accumulated depreciation
1,759
1,713
1,670
1,711
Property, plant, and equipment, net
2,069
2,103
2,141
2,175
Claims and advances
656
659
669
672
Operating lease asset
-
8
11
13
Total non-current assets
8,232
8,038
7,922
7,739
Total assets
9,496
9,185
9,712
9,743
Accounts payable
1,618
1,255
1,014
628
Accrued liabilities and others
664
892
1,142
886
Current loans
933
726
-
-
Total current liabilities
3,215
2,873
2,156
1,514
Long-term loans
-
-
131
132
Other liabilities
-
-
0
0
Operating lease liability
-
-
2
5
Non-current loans
149
191
-
-
Total non-current liabilities
149
191
133
137
Total liabilities
3,364
3,064
2,289
1,651
Common stock and additional paid-in capital, 0.0001 par value 600,000,000 shares authorized 102,417,178 and 95,038,026 shares issued and outstanding as of june 30, 2026, and december 31, 2025, respectively
142,065
139,122
138,014
135,774
Accumulated other comprehensive loss
-5,705
-5,709
-5,701
-4,854
Accumulated deficit
-130,228
-127,292
-124,890
-122,828
Total stockholders equity
6,132
6,121
7,423
8,092
Total liabilities and stockholders equity
9,496
9,185
9,712
9,743
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property, plant andequipment, gross$3,828K (-35.37%↓ Y/Y)Intangible assets, net$5,507K (175.76%↑ Y/Y)Property, plant, andequipment, net$2,069K (-33.19%↓ Y/Y)Claims and advances$656K (-3.53%↓ Y/Y)Inventory$640K (-52.56%↓ Y/Y)Cash and cashequivalents$331K (-27.09%↓ Y/Y)Deposits and advances$214K (0.94%↑ Y/Y)Accounts receivable, net$56K (-35.63%↓ Y/Y)Current investment$23K Less accumulateddepreciation$1,759K (-37.76%↓ Y/Y)Total non-currentassets$8,232K (42.18%↑ Y/Y)Total current assets$1,264K (-41.29%↓ Y/Y)Total assets$9,496K (19.55%↑ Y/Y)Total liabilities andstockholders equity$9,496K (19.55%↑ Y/Y)Total stockholdersequity$6,132K (0.89%↑ Y/Y)Total liabilities$3,364K (80.38%↑ Y/Y)Accumulated deficit-$130,228K (-6.44%↓ Y/Y)Accumulated othercomprehensive loss-$5,705K (-63.05%↓ Y/Y)Common stock andadditional paid-in...$142,065K (7.69%↑ Y/Y)Total currentliabilities$3,215K (86.38%↑ Y/Y)Total non-currentliabilities$149K (6.43%↑ Y/Y)Accounts payable$1,618K (73.42%↑ Y/Y)Current loans$933K Accrued liabilities andothers$664K (-16.16%↓ Y/Y)Non-current loans$149K

IGC Pharma, Inc. (IGC)

IGC Pharma, Inc. (IGC)